Depression in the Peruvian population and its associated factors: analysis of a national health survey

Depression in the Peruvian population and its associated factors: analysis of a national health survey
复制标题

DOI:
10.1016/j.jad.2020.03.100
复制
发表时间:
2020-08-01
影响因子:
6.6
通讯作者:
Nicolas Grendas, Leandro
Nicolas Grendas, Leandro
中科院分区:
医学2区
文献类型:
--
作者:
Hernandez-Vasquez, Akram;Vargas-Fernandez, Rodrigo;Nicolas Grendas, Leandro

文献摘要

被引文献

相似文献

背景:迄今为止,尚未描述与秘鲁人群出现抑郁或抑郁症状相关的因素。本研究旨在确定秘鲁人群中临床相关抑郁症状的患病率及其相关因素。方法:对 2018 年人口和家庭健康调查的二手数据进行横断面分析研究。该调查数据库包括 31,996 名 18 岁以上的参与者。分析的因变量是通过患者健康问卷 (PHQ-9) 测量的调查前 14 天内是否存在抑郁症。使用比例优势逻辑回归模型估计与抑郁存在相关的因素。结果:临床相关抑郁症状的总体患病率为 6.4%(中度和重度症状分别为 3.9% [95% CI: 3.6–4.3] 和 2.5% [95% CI: 2.2–2.7])。作为一名女性,属于 45 至 64 岁或 65 岁或以上年龄组,居住在安第斯地区,患有高血压或糖尿病或某些残疾,增加了出现临床相关抑郁症状的可能性。 局限性:使用 PHQ-9 工具评估抑郁症状将评估时间限制在调查前两周,需要进一步研究以确认诊断。结论:每 100 名秘鲁人中,有 6 人呈现中度至重度症状2018 年临床相关抑郁症状。抑郁症策略应考虑人群亚组,例如女性以及患有慢性病和残疾的患者。
Background:To date, the factors associated with the presence of depression or depressive symptoms in the Peruvian population have not been described. This study aimed to determine the prevalence of clinically relevant depressive symptoms in the Peruvian population and its associated factors.Methods:A cross-sectional analytical study of secondary data from 2018 Demographic and Family Health Survey was conducted. The survey database includes 31,996 participants over 18 years of age. The dependent variable of the analysis was the presence of depression during the 14 days before the survey measured by the Patient Health Questionnaire (PHQ-9). Factors associated with the presence of depression were estimated with a proportional odds logistic regression model.Results:The overall prevalence of clinically relevant depressive symptoms was 6.4% (moderate and severe symptomatology in 3.9% [95% CI: 3.6–4.3] and 2.5% [95% CI: 2.2–2.7], respectively). Being a woman, belonging to the age groups of 45 to 64 years or 65 or older, living in the Andean region, and having high blood pressure or diabetes mellitus or some disability increased the probability of having clinically relevant depressive symptoms.Limitations:The use of the PHQ-9 tool to assess depressive symptomatology limits the evaluation to a period of two weeks before the survey, requiring further study for diagnosis confirmation.Conclusion:Six out of 100 Peruvians presented moderate to severe clinically relevant depressive symptoms in 2018. Strategies for depression should contemplate population subgroups , such as women and patients with chronic diseases and disabilities.